All Stories

  1. Liver imaging reporting and data system category 4 observations in MRI: Risk factors predicting upgrade to category 5
  2. Radiologist income, receipts, and academic performance: an analysis of many nations
  3. Surrogate arterial phase imaging using a long duration (≈1.5 min) radial acquisition T1-weighted sequence: an alternative in patients unable to breath-hold
  4. Comparación de una secuencia en 3D con eco de gradiente potenciada en T1 con 3 factores de reducción de imagen en paralelo diferentes, en apnea y respiración libre, utilizando una bobina de 32 canales a 1,5T. Estudio preliminar
  5. Modification of Abdominal Fat Distribution After Aromatase Inhibitor Therapy in Breast Cancer Patients Visualized Using 3-D Computed Tomography Volumetry
  6. Response
  7. Dealing with Vascular Conundrums with MR Imaging
  8. Body MR Imaging
  9. Combined Chemical Shift Imaging With Early Dynamic Serial Gadolinium-Enhanced MRI in the Characterization of Adrenal Lesions
  10. Mass-forming cholangiocarcinoma and adenocarcinoma of unknown primary: can they be distinguished on liver MRI?
  11. Post-contrast T1-weighted sequences in pediatric abdominal imaging: comparative analysis of three different sequences and imaging approach
  12. Pelvis MRI: Introduction and Technique
  13. Imaging the Vagina and Urethra
  14. Imaging Maternal Conditions in Pregnancy
  15. Imaging the Adnexa
  16. Fetal Imaging
  17. In-phase and out-of-phase single-shot magnetization-prepared gradient recalled echo: Description and optimization of technique at 1.5T
  18. Secuencia de disparo único eco de gradiente en fase y fase opuesta con preparación de la magnetización: descripción y optimización de la técnica con equipo de 1,5 T
  19. Women's Imaging
  20. Perilesional enhancement of liver cavernous hemangiomas in magnetic resonance imaging
  21. Trends in Diagnostic CT Among Fee-For-Service Enrollees, 2000-2011
  22. Kidney Imaging
  23. Liver adenomatosis: serial investigation on MRI
  24. Text‐Atlas of Skeletal Age Determination
  25. Bone Marrow Maturation in Healthy and Diseased States
  26. Growth Failure and Pediatric Inflammatory Bowel Disease
  27. Skeletal Findings in Pediatric Oncology Patients
  28. Bone Age: Medico‐legal Issues
  29. Musculoskeletal Findings in Young Athletes
  30. Anatomic Aspects of Bone Ossification and their Magnetic Resonance Counterparts
  31. Maturation of Individual Bones of the Hand and Wrist in Healthy Children
  32. MRI Skeletal Age Estimation in Celiac Disease
  33. Skeletal Findings in Neurometabolic Disease
  34. MR Assessment of Skeletal Age in Healthy Children
  35. Nutrition and Growth
  36. Adult Bone Diseases That Begin in Childhood
  37. Bone Mineral Density Measured with DXA Method in Pediatric Inflammatory Bowel Diseases
  38. Endocrinology, Puberty, and Disorders of Pubertal Development
  39. Skeletal Findings in Genetic Disease
  40. Magnetic Resonance Imaging of Adenocarcinoma of the Pancreas
  41. Value of MRI of the hand and the wrist in evaluation of bone age: Preliminary results
  42. Radiation Dose Reduction
  43. Radiology Medical Education
  44. Patient Information
  45. Medicolegal Reform
  46. Quality Metrics for Radiology Practice
  47. Only Studies Which Are Necessary
  48. Pressures on Reduced Compensation for Clinical Service
  49. Alternate Imaging Studies to CT
  50. Research in Radiology
  51. Are We Doing The Right Study?
  52. National Health Care Systems
  53. Health Care Reform: The Scope of The Problem
  54. Health Care Reform in Radiology
  55. Outcomes of Patients with Elevated α-Fetoprotein Level and Initial Negative Findings at MR Imaging
  56. Enhancement of liver and pancreas on late hepatic arterial phase Imaging: Quantitative comparison among multiple gadolinium-based contrast agents at 1.5 tesla MRI
  57. Hepatic sarcoidosis: MR appearances in patients with chronic liver disease
  58. Free breathing three‐dimensional gradient echo‐sequence with radial data sampling (radial 3D‐GRE) examination of the pancreas: Comparison with standard 3D‐GRE volumetric interpolated breathhold examination (VIBE)
  59. Stomach Duodenum Magnetic Resonance Tomography
  60. Objective evaluation of acute adverse events and image quality of gadolinium-based contrast agents (gadobutrol and gadobenate dimeglumine) by blinded evaluation. Pilot study
  61. Whole-body MRI: comprehensive evaluation on a 48-channel 3T MRI system in less than 40 minutes. Preliminary results
  62. A novel tool for user-friendly estimation of natural, diagnostic and professional radiation risk: Radio-Risk software
  63. Enhancement of the liver and pancreas in the hepatic arterial dominant phase: Comparison of hepatocyte‐specific MRI contrast agents, gadoxetic acid and gadobenate dimeglumine, on 3 and 1.5 tesla MRI in the same patient
  64. Case report of systemic IgG-related disease affecting the pancreas and orbit
  65. Induction and repair of DNA double-strand breaks in blood lymphocytes of patients undergoing 18F-FDG PET/CT examinations
  66. Combined hepatocellular carcinoma‐cholangiocarcinoma: Report of MR appearance in eleven patients
  67. Effect of Antioxidants on X-ray–induced γ-H2AX Foci in Human Blood Lymphocytes: Preliminary Observations
  68. Low Quality and Lack of Clarity of Current Informed Consent Forms in Cardiology
  69. In-phase and out-of-phase gradient-echo imaging in abdominal studies: intra-individual comparison of three different techniques
  70. Debris-filled biliary system: a difficult diagnosis on MRI and MRCP
  71. MR enterography: Relationship between intestinal fold pattern and the clinical presentation of adult celiac disease
  72. The Information Imperative: Is It Time for an Informed Consent Process Explaining the Risks of Medical Radiation?
  73. Radiology's ethical responsibility for healthcare reform: Tempering the overutilization of medical imaging and trimming down a heavyweight
  74. Liver‐vessel cancellation artifact on in‐phase and out‐of‐phase MRI imaging: A sign of ultra‐high liver fat content
  75. Imaging the pregnant patient with abdominal pain
  76. Comparison of T1‐weighted in‐ and out‐of‐phase single shot magnetization‐prepared gradient‐recalled‐echo with three‐dimensional gradient‐recalled‐echo at 3.0 tesla: Preliminary observations in abdominal studies
  77. Reply
  78. Free-Breathing 3D T1-Weighted Gradient-Echo Sequence With Radial Data Sampling in Abdominal MRI: Preliminary Observations
  79. Radioprotection (un)awareness in cardiologists, and how to improve it
  80. Characterization of Adrenal Lesions With 1.5-T MRI: Preliminary Observations on Comparison of Three In-Phase and Out-of-Phase Gradient-Echo Techniques
  81. MR findings of lithium-related kidney disease: preliminary observations in four patients
  82. Realce por contraste de lesões hepáticas em pacientes com cirrose: estudo cruzado comparativo de dois agentes de contraste para RM realizado em uma única instituição. Resultados preliminares
  83. Bone metastases: Evaluation of acuity of lesions using dynamic gadolinium‐chelate enhancement, preliminary results
  84. MRI Findings of recurrent hepatocellular carcinoma after liver transplantation: Preliminary results
  85. Comparison of a single shot T1‐weighted in‐ and out‐of‐phase magnetization prepared gradient recalled echo with a standard two‐dimensional gradient recalled echo: Preliminary findings
  86. Focal Fat Masquerading as Malignancy in the Liver Graft of a Post-Transplant Patient
  87. Comparison of the incidence of pancreatic abnormalities between high risk and control patients: Prospective pilot study with 3 tesla MR imaging
  88. Reply
  89. Quarter-Dose (0.025 mmol/kg) Gadobenate Dimeglumine for Abdominal MRI in Patients at Risk for Nephrogenic Systemic Fibrosis: Preliminary Observations
  90. Short-term change in growth of uterine leiomyoma: tumor growth spurts
  91. Health Care Systems of Developed Non-U.S. Nations: Strengths, Weaknesses, and Recommendations for the United States—Observations From Internationally Recognized Imaging Specialists
  92. Hepatic tumor response evaluation by MRI
  93. Efficacy and Tolerability of Laparoscopic-assisted Radiofrequency Ablation of Hepatocellular Carcinoma in Patients Above 60 Years of Age
  94. Hemangioma hepático subcapsular com realce perilesional: achados de RM
  95. Management of branch-duct intraductal papillary mucinous neoplasms of the pancreas: observation with MR imaging
  96. Objective Determination of Standard of Care: Use of Blind Readings by External Radiologists
  97. MRI findings of rapidly progressive hepatocellular carcinoma
  98. Incidence of pulmonary embolism and other chest findings in younger patients using multidetector computed tomography
  99. Evaluation of Radiologist Interpretive Performance Using Blinded Reads by Multiple External Readers
  100. Improved Characterization of Focal Liver Lesions With Liver-Specific Gadoxetic Acid Disodium-Enhanced Magnetic Resonance Imaging
  101. Intraindividueller Vergleich von Gadobenat Dimeglumin (Gd-BOPTA) und Ferucarbotran bei der kontrastmittelverstärkten MRT von hepatozellulären Karzinomen
  102. Thermoablative Treatments for Malignant Liver Lesions: 10-Year Experience of MRI Appearances of Treatment Response
  103. Overlap syndrome of autoimmune chronic liver diseases: MRI findings
  104. Enhancement of abdominal organs on hepatic arterial phase: quantitative comparison between 1.5- and 3.0-T magnetic resonance imaging
  105. Nephrogenic Systemic Fibrosis: Change in Incidence Following a Switch in Gadolinium Agents and Adoption of a Gadolinium Policy—Report from Two U.S. Universities 1
  106. Nephrogenic systemic fibrosis versus contrast‐induced nephropathy: Risks and benefits of contrast‐enhanced MR and CT in renally impaired patients
  107. Feasibility of post-gadolinium three-dimensional gradient-echo sequence to evaluate the pulmonary arterial vasculature
  108. Quantitative and qualitative comparison of 3.0 T and 1.5 T MR imaging of the liver in patients with diffuse parenchymal liver disease
  109. MRI findings in nonalcoholic steatohepatitis: correlation with histopathology and clinical staging
  110. Nephrogenic Systemic Fibrosis and Management of High-risk Patients
  111. Early contrast enhancement of the liver: exact description of subphases using MRI
  112. MR imaging findings of small bowel hemorrhage: Two cases of mural involvement and one of perimural
  113. Quantitative and qualitative comparison of 1.5 and 3.0 tesla MRI in patients with chronic liver diseases
  114. MRI findings of posttraumatic intrahepatic vascular shunts
  115. Magnetic Resonance Imaging of Gallbladder and Biliary System
  116. Magnetic Resonance Imaging of Adenocarcinoma of the Pancreas
  117. Magnetic Resonance Imaging of Cystic and Endocrine Pancreatic Neoplasms
  118. Imaging the Kidneys
  119. Expression of Vascular Endothelial Growth Factor in Hepatocellular Carcinoma: Correlation with Radiologic Findings
  120. Growth of uterine leiomyomata among premenopausal black and white women
  121. MRI Evaluation of Treatment Response for Local Therapies for Malignant Liver Lesions
  122. Gadolinium- and superparamagnetic-iron-oxide-enhanced MR findings of intrapancreatic accessory spleen in five patients
  123. Risk of Nephrogenic Systemic Fibrosis: Evaluation of Gadolinium Chelate Contrast Agents at Four American Universities 1
  124. Primary Peritoneal Carcinoma
  125. When Should Abdominal Magnetic Resonance Imaging Be Used?
  126. 3.0-T MRI evaluation of patients with chronic liver diseases: initial observations
  127. Prospective comparison of high- and low-spatial-resolution dynamic MR imaging with sensitivity encoding (SENSE) for hypervascular hepatocellular carcinoma
  128. Water excitation MPRAGE: An alternative sequence for postcontrast imaging of the abdomen in noncooperative patients at 1.5 Tesla and 3.0 Tesla MRI
  129. The American College of Radiology white paper on radiation dose in medicine:deep impact on the practice of cardiovascular imaging
  130. Pancreatic cancer: Correlation of MR findings, clinical features, and tumor grade
  131. Magnetic resonance imaging of the liver: a review
  132. Liver MR Imaging: 1.5T versus 3T
  133. Focal pancreatic mass: Distinction of pancreatic cancer from chronic pancreatitis using gadolinium‐enhanced 3D‐gradient‐echo MRI
  134. Acute Cholecystitis: MR Findings and Differentiation from Chronic Cholecystitis 1
  135. Imaging strategies to reduce the risk of radiation in CT studies, including selective substitution with MRI
  136. MR Imaging Evaluation of the Adnexa
  137. Future Directions in MR Imaging of the Female Pelvis
  138. Emerging techniques: Whole‐body screening and staging with MRI
  139. Adult celiac disease: What is the role of MRI?
  140. Aneurysm of the inferior vena cava: case report
  141. Health effects of ionising radiation from diagnostic CT
  142. Magnetic resonance imaging of the liver: How I do it
  143. Accurate quantification of visceral adipose tissue (VAT) using water‐saturation MRI and computer segmentation: Preliminary results
  144. The Risk of Hepatocellular Carcinoma in Cirrhotic Patients with Small Liver Nodules on MRI
  145. Hepatocellular carcinoma missed on gadolinium enhanced MR imaging, discovered in liver explants: Retrospective evaluation
  146. Accuracy of magnetic resonance imaging for preoperative detection of portal vein thrombosis in liver transplant candidates
  147. Can the Relation between Gadopentetate Dimeglumine and FDG Uptake in Colorectal Liver Metastases Be Used Clinically?
  148. Hepatic Imaging
  149. Hepatic Imaging: Comparison of Modalities
  150. MR Imaging Findings in Autoimmune Hepatitis: Correlation with Clinical Staging
  151. Contrast Agents for MR Imaging of the Liver
  152. Pre-, Peri-, and Posttreatment Imaging of Liver Lesions
  153. Suspected Pancreatic Cancer: Evaluation by Dynamic Gadolinium-Enhanced 3D Gradient-Echo MRI
  154. Focal lesions in normal liver
  155. Magnetic Resonance Evaluation of Pregnant Patients with Acute Abdominal Pain
  156. Hepatocellular adenomas in men: MRI findings in four patients
  157. Magnetic Resonance Imaging of the Liver: Review of Techniques and Approach to Common Diseases
  158. Imaging and localization of islet-cell tumours of the pancreas on CT and MRI
  159. Liver Masses
  160. Future Horizons in MR Imaging
  161. MR Imaging of the Pancreas
  162. Hepatic nodules in liver transplantation candidates: MR imaging and underlying hepatic disease
  163. MRI findings of primary small-cell carcinoma of kidney
  164. Advances in Body MRI
  165. Future Directions in Body Magnetic Resonance Imaging
  166. Whole-Body Magnetic Resonance Imaging
  167. MRI of Acute Abdominal and Pelvic Pain in Pregnant Patients
  168. Magnetic Resonance Imaging of the Gastrointestinal Tract
  169. Magnetic Resonance Imaging Features of Focal Liver Lesions after Intervention
  170. Magnetic Resonance Imaging and Expression of Vascular Endothelial Growth Factor in Hepatocellular Nodules in Cirrhosis and Hepatocellular Carcinomas
  171. MRI findings of gastric metastases from breast carcinoma
  172. Immunoblastic large B-cell lymphoma of the peripancreatic head region: MR findings
  173. Angiogenesis in hepatocellular nodules: Correlation of MR imaging and vascular endothelial growth factor
  174. Early heterogeneous enhancement of the liver: Magnetic resonance imaging findings and clinical significance
  175. Undifferentiated (embryonal) sarcoma of the liver (USL): MRI findings including dynamic gadolinium enhancement
  176. MRI basic principles and applications. 3rd edn, by Mark A. Brown and Richard C. Semelka. Wiley‐Liss, Chichester, £32.50
  177. Does Hypervascularity of Liver Metastases as Detected on MRI Predict Disease Progression in Breast Cancer Patients?
  178. Modern hepatic imaging
  179. Cavernous hemangiomas in patients with chronic liver disease: MR imaging findings
  180. Abdominal imaging studies: comparison of diagnostic accuracies resulting from ultrasound, computed tomography, and magnetic resonance imaging in the same individual
  181. MRI: Basic Principles and Applications, 3rd edition
  182. Primary malignant mesothelioma of the liver: MR imaging findings
  183. Liver metastases from unknown primary site: demonstration on MR images
  184. Early-enhancing Non-neoplastic Lesions on Gadolinium-enhanced MRI of the Liver
  185. Spectrum of MRI Appearances of Untreated Metastases of the Liver
  186. MRI
  187. Hepatic MR Imaging with Ferumoxides: Multicenter Study of Safety and Effectiveness of Direct Injection Protocol1
  188. Liver metastases from pancreatic adenocarcinoma: MR imaging characteristics
  189. Autosomal dominant polycystic kidney disease: MR imaging evaluation using current techniques
  190. Hepatocellular carcinoma of diffuse type: MR imaging findings and clinical manifestations
  191. Renal cell carcinoma in a transplanted kidney: MR imaging findings
  192. Perilesional hyperintense rim of malignant hepatic tumors on ferumoxide‐enhanced T1‐weighted gradient‐echo MR images: Correlation between MR imaging and histopathologic findings
  193. Inflammatory Myofibroblastic Tumor of the Hepatobiliary System: Report of MR Imaging Appearance in Four Patients1
  194. MR Imaging Features of Primary Sclerosing Cholangitis: Patterns of Cirrhosis in Relationship to Clinical Severity of Disease1
  195. Giant hemangioma of the liver: MR imaging characteristics in 24 patients
  196. MR cholangiopancreatography
  197. MR imaging of diffuse liver disease
  198. Assessment of aorto‐iliac disease with magnetic resonance angiography using arterial phase 3‐d gradient‐echo and interstitial phase 2‐d fat‐suppressed spoiled gradient‐echo sequences
  199. MRI of the Male Pelvis
  200. Hepatobiliary Diseases. Pathophysiology and Imaging
  201. Gadolinium-enhanced MR Imaging of the Liver: Optimizing Imaging Delay for Hepatic Arterial and Portal Venous Phases—A Prospective Randomized Study in Patients with Chronic Liver Damage1
  202. Renal malacoplakia
  203. Epithelioid hemangioendothelioma of the liver
  204. MRI in staging of gastric cancer
  205. Preface
  206. MR imaging of the pediatric liver
  207. MR imaging of hepatic metastases
  208. Post-treatment malignant liver lesions: MR imaging
  209. Imaging the fatty liver
  210. MR imaging of benign hepatic tumors
  211. MR imaging of hepatocellular carcinoma
  212. Tumors of the Bladder and Urethra
  213. Magnetic resonance imaging of pulmonary parenchymal disease using a modified breath‐hold 3D gradient‐echo technique: Initial observations
  214. MRI of carcinoid tumors: Spectrum of appearances in the gastrointestinal tract and liver
  215. Acute renal failure: common occurrence of preservation of corticomedullary differentiation on MR images
  216. MR imaging findings of infectious cholangitis
  217. Exophytic benign tumors of the liver: appearance on MRI
  218. Radiologic diagnosis and staging of pancreatic ductal adenocarcinoma
  219. Radiologic features of cystic, endocrine and other pancreatic neoplasms
  220. Current Protocols in Magnetic Resonance Imaging
  221. MRI of the Liver
  222. MRI of the Kidney
  223. MRI of the Adrenal Glands
  224. MRI of the Pancreas
  225. MRI of the Female Pelvis
  226. Focal liver lesions: Comparison of dual‐phase CT and multisequence multiplanar MR imaging including dynamic gadolinium enhancement
  227. Adrenal adenomas: Characteristic postgadolinium capillary blush on dynamic MR imaging
  228. MRI Evaluation of the Liver
  229. Contrast Agents for MR Imaging of the Liver1
  230. Chronic hepatitis: Correlation of early patchy and late linear enhancement patterns on gadolinium-enhanced MR images with histopathology initial experience
  231. Efficacy and safety of mangafodipir trisodium (MnDPDP) injection for hepatic MRI in adults: Results of the U.S. Multicenter phase III clinical trials. Efficacy of early imaging
  232. Sequential use of gadolinium chelate and mangafodipir trisodium for the assessment of focal liver lesions:
  233. Extrahepatic abdominal imaging in patients with malignancy: Comparison of MR imaging and helical CT in 164 patients
  234. Hepatic alveolar echinococcosis: MRI findings
  235. Contrast-Enhanced 3D FISP MR Angiography of the Aortic Arch Ostia: Preliminary Results
  236. Evaluation of Crohn’s disease using half-fourier RARE and gadolinium-enhanced SGE sequences: Initial results
  237. Perilesional Enhancement of Hepatic Metastases: Correlation between MR Imaging and Histopathologic Findings—Initial Observations
  238. Neuroendocrine tumors of the pancreas: Spectrum of appearances on MRI
  239. Breath-hold 3D gradient-echo MR imaging of the lung parenchyma: Evaluation of reproducibility of image quality in normals and preliminary observations in patients with disease
  240. Spleen
  241. Polyposis syndromes of the gastrointestinal tract: MR findings
  242. Extrahepatic abdominal imaging in patients with malignancy: Comparison of MR imaging and helical CT in 164 patients
  243. Budd-chiari syndrome: Spectrum of appearances of acute, subacute, and chronic disease with magnetic resonance imaging
  244. Budd-chiari syndrome: Spectrum of appearances of acute, subacute, and chronic disease with magnetic resonance imaging
  245. Colon diseases: MR evaluation using combined T2-weighted single-shot echo train spin-echo and gadolinium-enhanced spoiled gradient-echo sequences
  246. Efficacy and safety of mangafodipir trisodium (MnDPDP) injection for hepatic MRI in adults: Results of the U.S. Multicenter phase III clinical trials. Efficacy of early imaging
  247. Nonendocrine Tumors of the Pancreas
  248. Safety and Efficacy of Mangafodipir Trisodium (MnDPDP) Injection for Hepatic MRI in Adults: Results of the U.S. Multicenter Phase III Clinical Trials (Safety)
  249. MR Imaging Abbreviations, Definitions, and Descriptions: A Review
  250. Stomach diseases: MR evaluation using combined t2-weighted single-shot echo train spin-echo and gadolinium-enhanced spoiled gradient-echo sequences
  251. Amphotericin B lipid complex for the treatment of patients with acute leukemia and hepatosplenic candidiasis
  252. Liver Metastases: Comparison of Current MR Techniques and Spiral CT during Arterial Portography for Detection in 20 Surgically Staged Cases1
  253. Hepatosplenic candidiasis in patients with acute leukaemia
  254. Islet cell tumor of the pancreas associated with tumor thrombus in the portal vein
  255. Biliary hamartomas: Solitary and multiple lesions shown on current MR techniques including gadolinium enhancement
  256. Biliary hamartomas: Solitary and multiple lesions shown on current MR techniques including gadolinium enhancement
  257. Common occurrence of benign liver lesions in patients with newly diagnosed breast cancer investigated by MRI for suspected liver metastases
  258. Common occurrence of benign liver lesions in patients with newly diagnosed breast cancer investigated by MRI for suspected liver metastases
  259. MRI of normal and abnormal duodenum using half-fourier single-shot RARE and gadolinium-enhanced spoiled gradient echo sequences
  260. Chemotherapy-treated liver metastases mimicking hemangiomas on MR images
  261. Magnetic resonance imaging of the abdominal aorta and iliac vessels using combined 3-D gadolinium-enhanced MRA and gadolinium-enhanced fat-suppressed spoiled gradient echo sequences
  262. Complex renal cysts: findings on MR imaging.
  263. Intrahepatic arterioportal fistula: gadolinium-enhanced 3D magnetic resonance angiography findings and angiographic embolization with steel coils
  264. Evaluation of a 10-minute Comprehensive MR Imaging Examination of the Upper Abdomen1
  265. Adrenal neuroblastoma in an adult with tumor thrombus in the inferior vena cava
  266. T2-weighted MRI of the uterus: Fast spin echo vs. breath-hold fast spin echo
  267. Extrahepatic Abdominal Imaging in Patients with Malignancy: Comparison of MR Imaging and Helical CT, with Subsequent Surgical Correlation
  268. Acute and subacute liver-related hemorrhage: MRI findings
  269. Magnetic resonance imaging of neuroblastoma using current techniques
  270. Incidental detection of acute myocardial infarction during routine performance of three-dimensional dynamic MR angiographic study with dynamic injection of gadolinium
  271. Pyogenic hepatic abscesses: MRI findings on T1- and T2-weighted and serial gadolinium-enhanced gradient-echo images
  272. Incidental detection of acute myocardial infarction during routine performance of three‐dimensional dynamic MR angiographic study with dynamic injection of gadolinium
  273. Cholangiocarcinoma: spectrum of appearances on MR images using current techniques
  274. Multiple pulmonary aneurysms secondary to Hughes‐Stovin syndrome: Demonstration by MR angiography
  275. Bowel-related abscesses: MR demonstration preliminary results
  276. Active intrahepatic gadolinium extravasation following TIPS
  277. Gastric stromal sarcomas: correlation of MR imaging and histopathologic findings in nine patients.
  278. Intraperitoneal abscesses: diagnostic accuracy of and appearances at MR imaging.
  279. MRI evaluation of acute renal trauma
  280. MR imaging of the small bowel using the HASTE sequence.
  281. Sequential use of ferumoxide particles and gadolinium chelate for the evaluation of focal liver lesions on MRI
  282. Metastatic Gastric Leiomyoblastoma: A Case Report
  283. Hepatocellular carcinoma in North America: a multiinstitutional study of appearance on T1-weighted, T2-weighted, and serial gadolinium-enhanced gradient-echo images.
  284. Fetal fast MR imaging: reproducibility, technical quality, and conspicuity of anatomy.
  285. Diagnosis and Monitoring Response to Treatment of Hepatosplenic Candidiasis in Patients with Acute Leukemia Using Magnetic Resonance Imaging
  286. Malignant hepatic tumors: Changes on MRI after hepatic arterial chemoembolization – preliminary findings
  287. Liver lesion detection, characterization, and effect on patient management: Comparison of single‐phase spiral CT and current MR techniques
  288. Normal placenta: gadolinium-enhanced dynamic MR imaging.
  289. Hepatosplenic fungal disease: diagnostic accuracy and spectrum of appearances on MR imaging.
  290. Immediate postgadolinium spoiled gradient‐echo MRI for evaluating the abdominal aorta in the setting of abdominal MR examination
  291. MRI of pancreatic tumors
  292. Nodular liver involvement in light chain multiple myeloma: Appearance on US and MRI
  293. Primary amenorrhea: evaluation with MR imaging.
  294. Abdominal granulocytic sarcomas: Demonstration by MRT
  295. Post radiation hemorrhagic cystitis: MR findings
  296. Adult intussusception: Demonstration by current MR techniques
  297. Littoral Cell Angioma in a Patient with Epstein Syndrome
  298. Ampullary carcinoma: Demonstration by current MR techniques
  299. MR Imaging of metastatic pancreatic VIPoma
  300. Angiosarcoma of the liver: MR imaging pre- and post-chemotherapy
  301. Focal hepatic lymphoma: Magnetic resonance demonstration using current techniques including gadolinium enhancement
  302. Renal cell cancer: Incidence of hemorrhage on MR images in patients with chronic renal insufficiency
  303. Small (<1,5 cm) angiomyolipomas of the kidney: Characterization by the combined use of in-phase and fat-attenuated MR techniques
  304. Pelvic fistulas: appearances on MR images
  305. Splenic hemangiomas and hamartomas: MR imaging characteristics of 28 lesions.
  306. Small bowel neoplastic disease: Demonstration by MRI
  307. Magnetic resonance imaging of the pelvic floor in the postpartum patient
  308. MR Imaging of the Gallbladder
  309. Case Report. Ultrasound and MR Findings in Acute Budd-Chiari Syndrome with Histopathologic Correlation
  310. Malignant fibrous histocytoma of the inferior vena cava: appearances on contrast-enhanced spiral CT and MRI
  311. HASTE MR imaging: Description of technique and preliminary results in the abdomen
  312. Pancreatic masses with inconclusive findings on spiral CT: Is there a role for MRI?
  313. Abdominal iron deposition: metabolism, MR findings, and clinical importance.
  314. Renal lymphoma: demonstration by MR imaging.
  315. MRI of Pancreatic Metastases from Renal Cancer
  316. Malignant lesions of the liver with high signal intensity on T1‐Weighted MR images
  317. Renal abscesses: appearance on gadolinium-enhanced magnetic resonance images
  318. MRI: Basic Principles and Applications
  319. Comparison of gadolinium chelates with manganese-DPDP for liver lesion detection and characterization: Preliminary results
  320. MR findings of intestinal graft-versus-host disease
  321. Multilocular cystic nephroma: MR imaging appearance with current techniques, including gadolinium enhancement
  322. MR findings in diffuse renal parenchymal disease
  323. Hepatic angiomyolipoma with minimal fat content: MR demonstration
  324. MRI of acute cholecystitis: Comparison with the normal gallbladder and other entities
  325. Malignant liver lesions: Comparison of spiral CT arterial portography and MR imaging for diagnostic accuracy, cost, and effect on patient management
  326. Dark ring sign: Finding in patients with fungal liver lesions and transfusional hemosiderosis undergoing treatment with antifungal antibiotics
  327. Correlation of perfusion abnormalities on CTAP and immediate postintravenous gadolinium-enhanced gradient echo MRI
  328. Enhancement of the normal pancreas: comparison of manganese-DPDP and gadolinium chelate
  329. Crohn??s Disease
  330. Transient increased segmental hepatic enhancement distal to portal vein obstruction on dynamic gadolinium‐enhanced gradient echo MR images
  331. Transitional cell carcinoma of the upper urinary tract: staging by MRI
  332. Endometriosis: Appearance and detection with conventional and contrast‐enhanced fat‐suppressed spin‐echo techniques
  333. CT and MRI of Hepatic Focal Nodular Hyperplasia with Peripheral Steatosis
  334. Anatomic changes in the pelvis after uncomplicated vaginal delivery: evaluation with serial MR imaging.
  335. Adrenocortical carcinoma: MR imaging appearance with current techniques
  336. Dynamic contrast-enhanced MR imaging of fibrolamellar hepatocellular carcinoma
  337. Foreword
  338. Magnetic Resonance Imaging of the Liver
  339. Magnetic Resonance Imaging of the Adrenal Gland and Kidney
  340. Magnetic Resonance Imaging of the Spleen and Pancreas
  341. ACTH-secreting islet cell tumor: Appearances on dynamic gadolinium-enhanced MRI
  342. Comparison of breath‐hold T1‐weighted MR sequences for imaging of the liver
  343. Bladder tumor staging: comparison of contrast-enhanced CT, T1- and T2-weighted MR imaging, dynamic gadolinium-enhanced imaging, and late gadolinium-enhanced imaging.
  344. Investigating bowel disease with ultrasound and MRI
  345. Hepatic hemangiomas: a multi-institutional study of appearance on T2-weighted and serial gadolinium-enhanced gradient-echo MR images.
  346. Hypervascular malignant liver lesions: comparison of various MR imaging pulse sequences and dynamic CT.
  347. Nodular sarcoidosis of the liver and spleen: Appearance on MR images
  348. Comparison of Magnetic Resonance Imaging and Endoscopy in Distinguishing the Type and Severity of Inflammatory Bowel Disease
  349. Malignant lesions of the liver identified on T1‐ but not T2‐weighted MR images at 1.5 T
  350. Solitary hepatic metastasis: Comparison of dynamic contrast‐enhanced CT and MR imaging with fat‐suppressed T2‐weighted, Breath‐hold T1‐weighted FLASH, and dynamic gadolinium‐enhanced FLASH sequences
  351. Ciliated hepatic foregut cysts: US, CT, and contrast-enhanced MR imaging
  352. Adenomyosis: prospective comparison of MR imaging and transvaginal sonography.
  353. Hepatobiliary MRI: A Text-Atlas at Mid and High Field
  354. Pocket Atlas of MRI of the Pelvis
  355. Renal corticomedullary differentiation: observation in patients with differing serum creatinine levels.
  356. MRI in the Diagnosis of Crohnʼs Disease in Two Pregnant Women
  357. Magnetic Resonance Imaging Evaluation of the Local Extent of Colorectal Mass Lesions
  358. MR imaging of the pancreas.
  359. Magnetic Resonance Imaging in Inflammatory Bowel Disease
  360. Renal cancer staging: Comparison of contrast‐enhanced CT and gadolinium‐enhanced fat‐suppressed spin‐echo and gradient‐echo MR imaging
  361. Magnetic Resonance Imaging of the Body
  362. Liver lesion detection: Comparison between excitation-spoiling fat suppression and regular spin-echo at 1.5T
  363. Evaluation of adrenal masses with gadolinium enhancement and fat‐suppressed MR imaging
  364. T2‐weighted MR imaging of focal hepatic lesions: Comparison of various RARE and fat‐suppressed spin‐echo sequences
  365. Islet cell tumors: comparison of dynamic contrast-enhanced CT and MR imaging with dynamic gadolinium enhancement and fat suppression.
  366. Chronic pancreatitis: MR imaging features before and after administration of gadopentetate dimeglumine
  367. Primary ovarian cancer: Prospective comparison of contrast‐enhanced CT and pre‐and postcontrast, fat‐ suppressed MR imaging, with histologic correlation
  368. Bile duct disease: Prospective comparison of ERCP, CT, and fat suppression MRI
  369. Dynamic Gd-DTPA enhanced breath-hold 1.5 t MRI of normal lungs and patients with interstitial lung disease and pulmonary nodules: preliminary results*
  370. Spleen: dynamic enhancement patterns on gradient-echo MR images enhanced with gadopentetate dimeglumine.
  371. Focal liver disease: comparison of dynamic contrast-enhanced CT and T2-weighted fat-suppressed, FLASH, and dynamic gadolinium-enhanced MR imaging at 1.5 T.
  372. Cardiac masses: Signal intensity features on spin‐echo, gradient‐echo, gadolinium‐enhanced spin‐echo, and TurboFLASH images
  373. Detection of acute and treated lesions of hepatosplenic candidiasis: Conparison of dynamic contrast‐enhanced CT and MR Imaging
  374. Renal lesions: controlled comparison between CT and 1.5-T MR imaging with nonenhanced and gadolinium-enhanced fat-suppressed spin-echo and breath-hold FLASH techniques.
  375. Breath-hold T2-weighted sequences of the liver: A comparison of four techniques at 1.0 and 1.5 T
  376. Pancreatic disease: prospective comparison of CT, ERCP, and 1.5-T MR imaging with dynamic gadolinium enhancement and fat suppression.
  377. Bowel disease: Prospective comparison of CT and 1.5‐T pre‐ and postcontrast MR imaging with T1‐weighted fat‐suppressed and breath‐hold FLASH sequences
  378. MR Imaging of the Pancreas at High Field Strength
  379. Carcinoma of the uterus: use of gadopentetate dimeglumine in MR imaging.
  380. T1-weighted sequences for MR imaging of the liver: comparison of three techniques for single-breath, whole-volume acquisition at 1.0 and 1.5 T.
  381. Right and left ventricular stroke volume measurements with velocity-encoded cine MR imaging: in vitro and in vivo validation.
  382. Normal and diffusely abnormal myocardium in humans: functional and metabolic characterization with P-31 MR spectroscopy and cine MR imaging.
  383. Combined gadolinium-enhanced and fat-saturation MR imaging of renal masses.
  384. Fat-saturation MR imaging of the upper abdomen.
  385. Interstudy reproducibility of dimensional and functional measurements between cine magnetic resonance studies in the morphologically abnormal left ventricle
  386. Obstructive nephropathy: evaluation with dynamic Gd-DTPA-enhanced MR imaging.
  387. Normal left ventricular dimensions and function: interstudy reproducibility of measurements with cine MR imaging.
  388. REPRODUCIBILITY OF CARDIAC MEASUREMENTS BY CINE MR IN NORMAL VOLUNTEERS BETWEEN SEQUENTIAL STUDIES
  389. Prosthetic testicle: appearance at MR imaging.
  390. Abdomen and Retroperitoneum
  391. MR imaging of the pancreas